TY - JOUR
T1 - Digital pathology transformation in a supraregional germ cell tumour network
AU - Colling, Richard
AU - Protheroe, Andrew
AU - Sullivan, Mark
AU - Macpherson, Ruth
AU - Tuthill, Mark
AU - Redgwell, Jacqueline
AU - Traill, Zoe
AU - Molyneux, Angus
AU - Johnson, Elizabeth
AU - Abdullah, Niveen
AU - Taibi, Andrea
AU - Mercer, Nikki
AU - Haynes, Harry R.
AU - Sackville, Anthony
AU - Craft, Judith
AU - Reis, Joao
AU - Rees, Gabrielle
AU - Soares, Maria
AU - Roberts, Ian S.D.
AU - Siiankoski, Darrin
AU - Hemsworth, Helen
AU - Roskell, Derek
AU - Roberts-Gant, Sharon
AU - White, Kieron
AU - Rittscher, Jens
AU - Davies, Jim
AU - Browning, Lisa
AU - Verrill, Clare
N1 - Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/12
Y1 - 2021/12
N2 - Background: In this article we share our experience of creating a digital pathology (DP) supraregional germ cell tumour service, including full digitisation of the central laboratory. Methods: DP infrastructure (Philips) was deployed across our hospital network to allow full central digitisation with partial digitisation of two peripheral sites in the supraregional testis germ cell tumour network. We used a survey-based approach to capture the quantitative and qualitative experiences of the multidisciplinary teams involved. Results: The deployment enabled case sharing for the purposes of diagnostic reporting, second opinion, and supraregional review. DP was seen as a positive step forward for the departments involved, and for the wider germ cell tumour network, and was completed without significant issues. Whilst there were challenges, the transition to DP was regarded as worthwhile, and examples of benefits to patients are already recognised. Conclusion: Pathology networks, including highly specialised services, such as in this study, are ideally suited to be digitised. We highlight many of the benefits but also the challenges that must be overcome for such clinical transformation. Overall, from the survey, the change was seen as universally positive for our service and highlights the importance of engagement of the whole team to achieve success.
AB - Background: In this article we share our experience of creating a digital pathology (DP) supraregional germ cell tumour service, including full digitisation of the central laboratory. Methods: DP infrastructure (Philips) was deployed across our hospital network to allow full central digitisation with partial digitisation of two peripheral sites in the supraregional testis germ cell tumour network. We used a survey-based approach to capture the quantitative and qualitative experiences of the multidisciplinary teams involved. Results: The deployment enabled case sharing for the purposes of diagnostic reporting, second opinion, and supraregional review. DP was seen as a positive step forward for the departments involved, and for the wider germ cell tumour network, and was completed without significant issues. Whilst there were challenges, the transition to DP was regarded as worthwhile, and examples of benefits to patients are already recognised. Conclusion: Pathology networks, including highly specialised services, such as in this study, are ideally suited to be digitised. We highlight many of the benefits but also the challenges that must be overcome for such clinical transformation. Overall, from the survey, the change was seen as universally positive for our service and highlights the importance of engagement of the whole team to achieve success.
KW - Digital
KW - Germ cell
KW - Pathology
KW - Testis
UR - http://www.scopus.com/inward/record.url?scp=85120171629&partnerID=8YFLogxK
U2 - 10.3390/diagnostics11122191
DO - 10.3390/diagnostics11122191
M3 - Article
AN - SCOPUS:85120171629
SN - 2075-4418
VL - 11
JO - Diagnostics
JF - Diagnostics
IS - 12
M1 - 2191
ER -